Atea Pharmaceuticals Inc.

AVIR | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.50

+$0.07 (+1.29%)

Sep 22, 2026, 10:35 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $434.55M

Enterprise Value $215.51M

Beta 0.29

Average Volume 325.35K

Shares Outstanding (Diluted) 80.05M

Shares Change YoY -4.41%

Institutional Ownership 75.88%

Exchange NASDAQ

ISIN US04683R1068

Price Performance

Price Change 1M 0.7%

Price Change 3M 21.2%

Price Change 6M 0.0%

Price Change YTD 56.0%

Price Change 1Y 85.3%

Price Change 3Y 69.7%

Price Change 5Y -83.1%

1M CAGR (ann.) 3.4%

1Y CAGR (ann.) 82.8%

5Y CAGR (ann.) -27.9%

All-Time CAGR -25.3%

Valuation

PE Ratio -2.61

Forward PE N/A

PEG Ratio 0.11

Forward PEG 0.10

PS Ratio N/A

Forward PS 14.50

PB Ratio 2.13

P/FCF Ratio -2.86

P/Adj. FCF Ratio -2.58

P/OCF Ratio -2.86

EV/Sales N/A

EV/EBIT -1.25

EV/EBITDA -1.26

EV/FCF -1.42

Earnings Yield -38.3%

FCF Yield -35.0%

Adj. FCF Yield -38.7%

Financial Health

Net Cash $219.47M

Total Debt $424K

Cash & Short-Term Investments $219.47M

Total Assets $232.28M

Current Ratio 8.13

Quick Ratio 8.13

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -358.66

Interest Coverage 0.00

Altman Z-Score 4.24

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -10.7%

Returns

Return on Assets -71.2%

Return on Equity -64.3%

Return on Invested Capital -86.3%

Return on Capital Employed -89.9%

Return on Tangible Assets -71.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 0.5%

EPS CAGR 5Y -34.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -11.8%

FCF CAGR 5Y -5.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 4

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.51

EPS Growth Est (next Q) -3.8%

Revenue Est (next Q) $50.45M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $7

Price Target Upside 28.9%

Cash Flow

Operating Cash Flow $-152.07M

Free Cash Flow $-152.07M

Adj. Free Cash Flow $-168.29M

FCF Per Share -$1.90

OCF Per Share -$1.90

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-38.34M

Operating Income $-183.61M

EBITDA $-171.27M

Net Income $-165.29M

EPS (Diluted) -$2.08

Revenue / Employee N/A

Profit / Employee $-3.01M

Employees 55